News

Jacobio Pharmaceuticals has announced  the U.S. Food and Drug Administration (FDA) has approved company's Investigational New Drug (IND) application to develop a KRAS G12C inhibitor.…
Read More...

Thermo Fisher Scientific, the world leader in serving science, today launched the Thermo Scientific E-CFEG, the company's new cold field emission gun and a value-added component for the…
Read More...

Pfizer Inc. announced that it has acquired Amplyx Pharmaceuticals, Inc., a privately-held company dedicated to the development of therapies for debilitating and life-threatening…
Read More...

Mesoblast Limited announced the 60 day results from the randomized controlled trial of remestemcel-L in 222 ventilator-dependent COVID-19 patients with moderate/severe acute respiratory…
Read More...

osteolabs GmbH announces the formation of osteolabs UK Limited in Marlow near London. osteolabs UK is a Joint Venture between osteolabs GmbH as majority shareholder and Christopher…
Read More...

Brooklyn ImmunoTherapeutics LLC announced it has acquired an exclusive license for mRNA gene editing and cell therapies technology of Factor Bioscience Limited and Novellus Therapeutics…
Read More...

Sirnaomics Biopharmaceuticals (Suzhou) Co. Ltd., a subsidiary of Sirnaomics, Inc., a biopharmaceutical company engaged in the discovery and development of RNAi therapeutics against…
Read More...

Catalent, the leading global provider of advanced delivery technologies, development, manufacturing, and clinical supply solutions for drugs, biologics, cell and gene therapies, and…
Read More...

Celltrion Group announced the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive scientific opinion for the company’s…
Read More...

ADMA Biologics, Inc. an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, announced that the U.S.…
Read More...

Implandata Ophthalmic Products, a digital health company with offices in Germany and San Diego, California has announced that its game-changing EYEMATE system for digitally enabled…
Read More...

ESSA Pharma Inc. clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, announced that the Company has entered into a clinical…
Read More...

Toxys and Unilever Safety and Environmental Assurance Centre (SEAC) have entered into an agreement to further validate and expand the ReproTracker assay. Testing for developmental…
Read More...

Rentschler Biopharma and Vetter, two globally operating Contract Development and Manufacturing Organizations (CDMOs), announced that their strategic collaboration has taken key steps…
Read More...

GenScript announced the launch of its Research Lentiviral Vector Packaging Service for cell line development, gene editing, and drug discovery. The service enables scientists to package…
Read More...

LogicBio Therapeutics, Inc. a clinical-stage genetic medicine company pioneering gene delivery and gene editing platforms to address rare and serious diseases from infancy through…
Read More...

Merck known as MSD outside the United States and Canada, announced that the company has entered into non-exclusive voluntary licensing agreements for molnupiravir with five established…
Read More...

Geneseeq Technology Inc. and AstraZeneca are excited to announce their strategic collaboration to establish a Bio-Diagnostic Innovation Center in Guangzhou, China. The center is…
Read More...

ProBioGen AG announced that Asher Biotherapeutics, Inc., has entered into a service agreement covering all aspects of cell line development, process development and GMP manufacturing at…
Read More...

Mirum Pharmaceuticals, Inc. announced that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for a patent application No. 16/994,368. The…
Read More...